|
|
|
Großansicht des Bildes mit der Bildunterschrift: The mutation is associated with more severe symptoms, but is not resistant to antiviral drugs The mutation may have caused more severe symptoms in those infected. Two of the...
Inovio, Merck gain; Novavax falls in afternoon action , MarketWatch BOSTON (MarketWatch) -- Drug stocks were mostly higher Friday while shares of Inovio Biomedical soared on positive clinical data for its new DNA-based flu...
AMA Vice President, Dr Steve Hambleton, said today that the AMA is encouraging people to visit their GP to be immunised against swine flu. It has been reported that there are still far too many Australians who have not been...
SAINT-CLOUD, France, November 20 /PRNewswire/ -- Dassault Falcon has received Type Certificate for the Falcon 7X from the Director General of Civil Aviation (DGCA) in India, confirming that the Falcon 7X meets the rigorous...
Antigenics Withdraws Oncophage Application In Europe Following Negative Recommendation (AP) LEXINGTON, Mass. (AP) - Biotechnology company Antigenics Inc. said Friday it will not seek approval for a potential kidney cancer...
EMEA says single dose of Glaxo, Novartis vaccines enough * Agency still evaluating data on Baxter H1N1 vaccine (Adds details on manufacturers, background) LONDON, Nov 20 (Reuters) - In a change of tack, Europe's drugs watchdog...
Merck fertility drug receives positive recommendation by European advisory committee WHITEHOUSE STATION, N.J. November 20, 2009 (AP) The Associated Press Post a Comment Drug developer Merck & Co. said Friday a European advisory...
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck&Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA®...
9:02AM Met-Pro Corp misses by $0.05, misses on revs 9.34 : Reports Q3 (Oct) earnings of $0.07 per share, $0.05 worse than the First Call consensus of $0.12; revenues fell 29.3% year/year to $19.8 mln vs the $22.6 mln consensus....
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous...
